Ionis to hold first quarter 2023 financial results webcast

Rhea-AI Summary

Ionis Pharmaceuticals has announced a live webcast scheduled for May 3, 2023, at 11:30 a.m. Eastern Time, to discuss its first quarter 2023 financial results. This event will provide insights into the company's financial performance, emphasizing its leadership in RNA-targeted therapies. Ionis has over three decades of experience and currently boasts three marketed medicines alongside a robust late-stage pipeline focused on cardiovascular and neurological treatments. Stakeholders can access the webcast and follow up with a replay through Ionis' investor relations page.

Positive

• Ionis has over 30 years of experience in RNA-targeted therapy.
• The company has three marketed medicines.
• The late-stage pipeline includes cardiovascular and neurological franchises.

Negative

• None.

Webcast scheduled for Wednesday, May 3 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., April 20, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, May 3^rd at 11:30 a.m. Eastern Time to discuss its first quarter 2023 financial results.

The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-first-quarter-2023-financial-results-webcast-301802455.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When will Ionis Pharmaceuticals announce its first quarter 2023 financial results?

Ionis Pharmaceuticals will announce its first quarter 2023 financial results on May 3, 2023.

How can I access the Ionis Pharmaceuticals webcast for financial results?

The Ionis Pharmaceuticals webcast for financial results can be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events.

What is Ionis Pharmaceuticals' focus in drug development?

Ionis Pharmaceuticals focuses on RNA-targeted therapies, particularly in cardiovascular and neurological areas.

What significant milestones has Ionis Pharmaceuticals achieved?

Ionis Pharmaceuticals has achieved the launch of three marketed medicines and has a strong late-stage pipeline.